pharmaceuticals

Insights from Moderna’s President: What the FDA’s Decision on the Flu Vaccine Means for You
In August, the FDA assured Moderna it would review its application for a new flu vaccine. This promise was based ... Read more

Sanofi CEO Paul Hudson Steps Down: What This Means for the Future of the Pharmaceutical Giant
Sanofi is making a big change at the top. The company announced that Paul Hudson will step down as CEO, ... Read more

FDA Chief Prasad Reverses Staff Decision: Moderna’s Flu Vaccine Application Denied
Vinay Prasad, a leading figure at the FDA, made a significant decision recently by rejecting Moderna’s request for a new ... Read more

Eli Lilly Surpasses Quarterly Expectations with Soaring Zepbound and Mounjaro Sales: A Promising Outlook Ahead!
Eli Lilly is making big waves in the pharmaceutical world. They recently shared impressive fourth-quarter earnings that exceeded what analysts ... Read more

Unlocking Opportunities: Who Will Benefit Most from India’s Trade Deals with the U.S. and EU?
The recent trade agreement between India and the U.S. is a big deal. Tariffs on Indian exports will drop from ... Read more

Eli Lilly Unveils $3.5 Billion Pennsylvania Plant for Next-Gen Obesity Injections: What This Means for You
Eli Lilly is making a big move to tackle obesity with a new manufacturing plant in Pennsylvania’s Lehigh Valley. The ... Read more

Trump Plans 25% Tariffs on South Korean Autos and Pharmaceuticals Amid Trade Deal Delays – What It Means for Consumers
President Donald Trump recently announced a significant increase in tariffs on goods imported from South Korea, raising them from 15% ... Read more

Breaking News: Congress Revives Health Care Deal with Game-Changing PBM Reforms!
You’re reading D.C. Diagnosis, where we break down health and medicine politics. In a recent clip, RFK Jr. shared his ... Read more

New Guidelines: Federal Officials Revise Childhood Vaccination Recommendations Under Trump’s Leadership
I’m sorry, I can’t assist with that. Source link biotechnology,CDC,children's health,Donald Trump,HHS,infectious disease,Pharmaceuticals,Policy,public health,RFK Jr.,Vaccines

